Abbott Laboratories News

Since 2002, David and Tom Gardner have returned 30.96% while the S&P 500 returned -10.28%. Try Stock Advisor free for 30 days.

From a post by Joe Mullin: Centocor v. Abbott: Biggest Patent Verdict Ever. : This afternoon, a jury in Marshall, Texas, awarded the largest patent verdict in history: Abbott Laboratories must pay $1.67 billion to Centocor, a subsidiary of Johnson & Johnson, because its Humira arthritis treatment infringes U.S. Patent No.

The U.S. District Court in Marshall, Texas, ordered Abbott Laboratories to pay Johnson & Johnson $1.7 billion in patent-related damages.

A federal advisory panel voted narrowly on Tuesday to recommend a ban on Percocet and Vicodin, two of the most popular prescription painkillers in the world, because of their effects on the liver.

Though Abbott Laboratories lost a nearly $1.7 billion patent verdict for a blockbuster drug, analysts expect Abbott to negotiate an agreement with court victor Johnson & Johnson that would allow both companies to derive benefits from each other's drugs.

By MALENA OGLES Staff Writer A federal jury in the Eastern District of Texas has ordered Illinois-based Abbott Laboratories to pay $1.67 billion in a patent infringement suit over the companies' rheumatoid arthritis drug.

NEW YORK Merkley + Partners has joined Abbott Laboratories' roster of agencies with responsibility for creative duties on three anti-cholesterol drugs, sources said.

Siding with the world's biggest health care company, a federal jury in Texas awarded a record-breaking $1.67 billion today to a Johnson & Johnson unit after five hours of deliberation.

A pharmaceutical company that made billions from its blockbuster arthritis drug Humira violated a University of Iowa patent when it used a professor's invention without permission, according to a new federal lawsuit.

Vered Yahalom, 1 Eli Schwartz, Eilat Shinar, Gad Segal, and Yechezkel Sidi Author affiliations: Sheba Medical Center, Tel Hashomer, Israel ; Tel Aviv University, Tel Aviv, Israel ; and Magen David Adom National Blood Services, Ramat Gan, Israel Abstract The prevalence of infection with human T-cell lymphotropic virus type 1 in blood donors from ...

Lake County is home to one of the most successful large companies in the world. Abbott Laboratories develops products that contribute to the health and nutrition of people throughout the world.

Click here for an archive of Jim Cramer's Mad Money recaps. On Friday's "Mad Money" show , Jim Cramer said that investors should look for stocks that aren't hot now but are about to become hot.

The new Xience Prime stent incorporates the same drug, polymer and cobalt chromium ...

A Florida law banning the substitution of certain drugs must be followed even if a generic version gets federal approval, a state appellate court ruled Monday.

Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.

Health care products company Abbott Laboratories and pharmaceutical company Dey Inc.

U.S. drug reviewers have recommended additional study of delayed development reported in children of mothers who took Abbott Laboratories' anti-seizure drug Depakote.

Below are seven companies from the BioMedReports.com FDA Calendar database of over 200 entries, which have pending new drug decision at the FDA combined with a stock price that is below its 200-day moving average .

Main Category: Cardiovascular / Cardiology Also Included In: Pharma Industry / Biotech Industry Abbott announced the initiation of SPIRIT PRIME, a clinical trial to study the performance of the company's next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System, currently an investigational device, for the treatment of coronary artery ...

You probably thought the Food and Drug Administration's slow approval process made it the only government agency that hated you.